Gutron (Midodrine Hydrochloride)

Gutron is indicated for the management of orthostatic hypotension, a condition characterized by a significant drop in blood pressure upon standing.

• Improves standing systolic blood pressure in patients with chronic orthostatic hypotension.
• Reduces episodes of dizziness, light‑headedness, or visual disturbances related to postural blood pressure decline.
• May be used as adjunct therapy when non‑pharmacologic measures (e.g., compression stockings, increased fluid intake) are insufficient.
• Provides symptomatic relief to improve daily activities and reduce fall risk in elderly patients.
• Can be considered for patients with neurogenic orthostatic hypotension secondary to autonomic dysfunction.

The safety profile of Gutron reflects the pharmacologic action of Midodrine Hydrochloride; side effects are reported across a range of frequencies.

Common

• Piloerection (goose‑skin appearance) especially on the arms and torso.
• Itching or mild skin rash at the site of drug effect.
• Urinary urgency or frequency.
• Supine hypertension (elevated blood pressure while lying down).

Serious

• Severe supine hypertension that may require medical intervention.
• Cardiovascular events such as angina or arrhythmia in susceptible individuals.
• Reflex bradycardia or syncope due to excessive vasoconstriction.

Clinicians should evaluate individual risk factors before prescribing Gutron and monitor patients regularly for adverse reactions.

• Assess baseline blood pressure in both seated and supine positions.
• Avoid use in patients with uncontrolled hypertension or severe cardiac disease.
• Counsel patients to remain upright for at least 3–4 hours after each dose.
• Monitor for signs of supine hypertension, especially during nighttime.
• Adjust dose or discontinue if significant hypertension or cardiovascular symptoms develop.
• Use caution in patients with renal or hepatic impairment, as drug clearance may be altered.
• Pregnancy and lactation status should be reviewed; safety data are limited.

Midodrine Hydrochloride can interact with several medications that affect blood pressure or vascular tone, requiring careful management.

Avoid

• Other alpha‑adrenergic agonists (e.g., phenylephrine) that may cause additive hypertension.
• Monoamine oxidase inhibitors (MAOIs) combined with sympathomimetic agents.
• Direct vasopressors such as norepinephrine infusions.

Use with caution

• Antihypertensive agents (e.g., ACE inhibitors, beta‑blockers, diuretics) which may blunt the pressor effect.
• Central nervous system depressants that could mask symptoms of hypertension.
• Drugs that influence renal excretion (e.g., NSAIDs) potentially affecting Midodrine clearance.